Concomitant Therapy of H. Pylori

• Status: Unknown status
• Trial end date: 2014-02-01
• Target enrollment: 0
• Participant gender: All

Summary

If we compare eradication rate of Helicobacter pylori divided to 4 groups: amoxicillin, rabeprazole, clarithromycin(AOC), amoxicillin, rabeprazole, metronidazole(AOM), treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days(sequential), amoxicillin, clarithromycin, metronidazole, rabeprazole(concomitant), then the eradication rate of concomitant group will be the highest.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Catholic University of Korea
• Collaborators: Bucheon St. Mary's Hospital; St. Vincent's Hospital-Manhattan; St. Vincent's Medical Center
• Treatments: Amoxicillin; Clarithromycin; Metronidazole; Rabeprazole

Criteria

Inclusion Criteria:

• patients infected with Helicobacter pylori

Exclusion Criteria:

• cancer

• pregnancy

• formerly treated with eradication